CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.62B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.92: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
154.04BINR1.62B · vs all stocks (USD)
Trailing P/E
116.24xvs Medical Instruments & Supplies peers
Revenue (TTM)
20.80BINR218.47M · vs all stocks (USD)
Profit Margin
6.40%vs Medical Instruments & Supplies peers
52-Week Change
9.41%vs all stocks
Market Capitalization
154.04BINR1.62B · vs all stocks (USD)
Enterprise Value
163.15BINR1.71B · vs all stocks (USD)
Trailing P/E
116.24xvs Medical Instruments & Supplies peers
Forward P/E
58.64xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.41xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.62xvs Medical Instruments & Supplies peers
Enterprise to Revenue
7.84xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
28.64xvs Medical Instruments & Supplies peers
Gross Margin
65.12%vs Medical Instruments & Supplies peers
Profit Margin
6.40%vs Medical Instruments & Supplies peers
Operating Margin
15.03%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.82%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
8.31%vs Medical Instruments & Supplies peers
Revenue (TTM)
20.80BINR218.47M · vs all stocks (USD)
Revenue per Share (TTM)
65.75INRUpdated Jul 19, 2026Quarterly Revenue Growth
22.60%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
9.24BINR97.09M · vs all stocks (USD)
EBITDA (TTM)
6.14BINR64.49M · vs all stocks (USD)
Net Income (TTM)
1.33BINR13.99M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
5.19BINR54.51M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-377.46MINR-3.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00INRUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
942.40MINRFY2026 · Mar 31, 2026Revenue
20.80BINRFY2026 · Mar 31, 2026Cost of Goods Sold
7.52BINRFY2026 · Mar 31, 2026Gross Profit
13.28BINRFY2026 · Mar 31, 2026Operating Income
2.93BINR30.81M · vs all stocks (USD)
Pre-tax Income
2.49BINRFY2026 · Mar 31, 2026Income Tax Expense
805.00MINRFY2026 · Mar 31, 2026Net Income
1.68BINRFY2026 · Mar 31, 2026EBIT
3.39BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
6.14BINRFY2026 · Mar 31, 2026Other Operating Expenses
3.55BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
904.60MINRFY2026 · Mar 31, 2026Minority Interests (P&L)
-349.50MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
2.57BINRFY2026 · Mar 31, 2026Free Cash Flow
2.56BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
905.50MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
2.49BINRFY2026 · Mar 31, 2026Stock-based Compensation
73.90MINRFY2026 · Mar 31, 2026Other Non-cash Items
776.10MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-541.20MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-221.90MINRFY2026 · Mar 31, 2026Capital Expenditures
8.60MINRFY2026 · Mar 31, 2026Net Acquisitions
-913.40MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-904.80MINRFY2026 · Mar 31, 2026Long-term Debt Issuance
0.00INRFY2026 · Mar 31, 2026Long-term Debt Payments
-896.00MINRFY2026 · Mar 31, 2026Common Dividends Paid
-10.90MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-793.20MINRFY2026 · Mar 31, 2026Shares Outstanding
316.81MSharesUpdated Jul 19, 2026Float Shares
60.55MSharesUpdated Jul 19, 2026% Held by Insiders
75.47%vs all stocks
% Held by Institutions
19.30%vs all stocks
Total Cash (MRQ)
2.82BINR29.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.86INRUpdated Jul 19, 2026Total Debt (MRQ)
10.66BINR111.98M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5030xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.24xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
63.76INRUpdated Jul 19, 2026Total Assets
39.42BINR414.00M · vs all stocks (USD)
Total Current Assets
5.73BINRFY2026 · Mar 31, 2026Total Liabilities
18.22BINRFY2026 · Mar 31, 2026Total Non-current Assets
33.69BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
13.61BINRFY2026 · Mar 31, 2026Total Current Liabilities
4.61BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
905.50MINRFY2026 · Mar 31, 2026Other Short-term Investments
2.04BINRFY2026 · Mar 31, 2026Accounts Receivable
1.61BINRFY2026 · Mar 31, 2026Inventory
940.30MINRFY2026 · Mar 31, 2026Accounts Payable
1.49BINRFY2026 · Mar 31, 2026Short-term Debt
1.15BINRFY2026 · Mar 31, 2026Other Current Liabilities
287.90MINRFY2026 · Mar 31, 2026Long-term Debt
9.51BINRFY2026 · Mar 31, 2026Common Stock (Book)
316.80MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
21.20BINR222.63M · vs all stocks (USD)
52-Week Low
401.00INRUpdated Jul 19, 202652-Week High
568.00INRUpdated Jul 19, 202652-Week Change
9.41%vs all stocks
50-Day MA
467.89INRUpdated Jul 19, 2026200-Day MA
473.39INRUpdated Jul 19, 2026Avg 10-Day Volume
106.85KSharesUpdated Jul 19, 2026Avg 30-Day Volume
80.89KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
4.18INRUpdated Jul 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Backed Growth Configuration
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.65Profit Margin: 0.06
Financial Health
Altman Z-Score 5.92: safe zoneNotable
Altman Z-Score: 5.92
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.62B, above the global median of $1.15BNotable
Market cap (USD): 1,617,913,830.122Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Tayho Advanced Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Tianrun Industry Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Adient plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Wanrun New Energy Technology Company Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Personalis Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Paradeep Phosphates Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Pylon Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Micronics Japan Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
T1 Energy Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Jame Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Happy Forgings Ltd
3 interpretationsCash-Backed Growth ConfigurationIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue And Profit Growth
Ramkrishna Forgings Ltd.
3 interpretationsCash-Backed Growth ConfigurationIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue And Profit Growth
Banco Products (India) Ltd.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue And Profit Growth